Hector Guadalajara

Head

Hospital Universitario Fundación Jiménez Díaz

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Hector Guadalajara is the Head at Hospital Universitario Fundación Jiménez Díaz in Spain. His research primarily focuses on neoadjuvant therapies for rectal cancer, patient decision-making in breast cancer treatments, and innovative surgical techniques such as robotic transanal minimally invasive surgery. He has contributed to significant studies in areas including gene methylation in tumor response and the effectiveness of chimeric antigen receptor T cell therapies in colorectal cancer. His work emphasizes a patient-centered approach to surgical and therapeutic outcomes.

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (5)

Manuel Artiles-Armas

Universidad Fernando Pessoa Canarias

SPAIN

View details

Sebastiano Biondo

SPAIN

View details

Olatz Lopez-Fernandez

Profesora

Centro de Enseñanza Superior Cardenal Cisneros

SPAIN

View details

Damián García-Olmo

SPAIN

View details

pedro villarejo campos

Associate Professor

Universidad Complutense de Madrid Facultad de Medicina

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hector Guadalajara

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Inflammatory Fibroid Polyp (Vanek’s Tumor): A Retrospective Multicentric Analysis of 67 Cases

The Implementation of Shared Decision-Making Using Patient Decision Aid Tools to Select Breast Cancer Treatment Options: A Systematic Review in the Time of Minimum Quality Standards

Total neoadjuvant therapy in rectal cancer: The FOREST protocol, a patient‐centered approach that clusters two cohorts with different outcomes

Pre-Treatment SEPTIN9 Gene Methylation Ratio Predicts Tumor Response to Total Neoadjuvant Therapy in Patients with Locally Advanced Rectal Cancer

Decalogue for mastering robotic transanal minimally invasive surgery (rTAMIS)

Correction to: Cecum to pelvis technique: a simple and autologous solution to prevent postoperative complications in pelvic surgery

Cecum to pelvis technique: a simple and autologous solution to prevent postoperative complications in pelvic surgery

Intraperitoneal administration of carcinoembryonic antigen-directed chimeric antigen receptor T cells is a robust delivery route for effective treatment of peritoneal carcinomatosis from colorectal cancer in pre-clinical study

Robotic transanal minimally invasive surgery for the regrowth of rectal cancer following a watch-and-wait approach – a video vignette

Epidemiology, oncologic results and risk stratification model for metachronous peritoneal metastases after surgery for pT4 colon cancers: results from an observational retrospective multicentre long-term follow-up study

Misconceptions, hurdles and recommendations regarding the use of mesenchymal stem/stromal cells in perianal Crohn disease

Proyección de patología de salud mental en estudiantes de Medicina y su relación con la docencia y pandemia por COVID-19.

Study of the Effect of Wild-Type and Transiently Expressing CXCR4 and IL-10 Mesenchymal Stromal Cells in a Mouse Model of Peritonitis

Misconceptions, hurdles and recommendations regarding the use of mesenchymal stem/stromal cells in perianal Crohn disease

Collaborators (5)

Manuel Artiles-Armas

Sebastiano Biondo

Olatz Lopez-Fernandez

Damián García-Olmo

pedro villarejo campos

Make your next move.